Loved your last sentence. Reflect on it at length from your...

Loved your last sentence. Reflect on it at length from your lofty perch.

Those who have finally had a gutful of this Company, and all that goes with it, are not psychologically unsound at all. It is instead those,who, even in the face of years of a plummeting SP caused wholely by the Company itself, still call out..you're all crazy, buy more, buy more.They are the Cellmid deniers, the Buy/Held Brigade, the cheer squad.The SP of 99c-$1.59 in 2-3 years dreamers. Who do not "move on to a potentially more rewarding investment".

This Company certainly is now at the crossroads. One road leads to oblivion, the other to a maybe. And, IMO, that maybe will not include any royalties from the Midkine patents. Maria, Bart, Fintan, Fintan's Company and that other Company engaged with Fintan's (I forget the name), have all apparently failed to convince Global Pharmaceutical/Medical Companies that testing for the presence of Midkine is profitable. IMO, this last resort attempt will also fail.

And that, of course, is a crying shame. The early detection of any disease,especially cancer, should not be tied to the bottom line. Despite the acknowledged medical worth of early Midkine detection, that appears to be the case.

So, Cellmid is left with Evolis, and possibly, possibly, some skin and body products. Certainly nothing there that leads to a SP jump of 2200% in three years. Even the Covid test kit insanity last year could only manage a very temporary 500% spike before back to the regulation share price slide to what is now close to an all time historical low. Certainly nothing there that cries out... buy now buy now.... And the investing community knows that.

And you imply that a sell/held sentiment does not make sense. Check on your own sentiment. Where is the sense of that over the last ten years?

IMO DYOR